Calidi Biotherapeutics (CLDI) Net Cash Flow (2022 - 2025)
Calidi Biotherapeutics (CLDI) posted quarterly Net Cash Flow of -$4.8 million for Q4 2025, down 162.39% year-over-year from $7.7 million in Q4 2024, and down 191.85% quarter-over-quarter from $5.2 million in Q3 2025.
Calidi Biotherapeutics (CLDI) Net Cash Flow (2022 - 2025) Analysis & Trends
Calidi Biotherapeutics' Net Cash Flow history runs 4 years deep, the most recent figure standing at -$4.8 million for Q4 2025.
- In Q4 2025, Net Cash Flow fell 162.39% year-over-year to -$4.8 million; the TTM figure through Dec 2025 stood at -$4.0 million (down 152.4% YoY), while the FY2025 annual figure was -$4.0 million, down 152.4% from the prior year.
- Net Cash Flow for Q4 2025 stood at -$4.8 million, down from $5.2 million in the prior quarter.
- The five-year high for Net Cash Flow was $8.1 million in Q3 2023, with the low at -$8.2 million in Q4 2023.
- The 4-year median for Net Cash Flow is $6660.5 (2022), against an average of $225375.0.
- Peak annual rise in Net Cash Flow reached 789.02% in 2023, while the deepest fall reached 3000.35% in 2023.
- Calidi Biotherapeutics' Net Cash Flow stood at $282000.0 in 2022, then tumbled by 3000.35% to -$8.2 million in 2023, then soared by 193.87% to $7.7 million in 2024, then slumped by 162.39% to -$4.8 million in 2025.
- Business Quant data shows CLDI's Net Cash Flow at -$4.8 million in Q4 2025, $5.2 million in Q3 2025, and -$5.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.79 Mn |
| Dec 31, 2025 | -4.79 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | -5.41 Mn |
| Jun 30, 2025 | -5.41 Mn |
| Mar 31, 2025 | 970,000.00 |
| Mar 31, 2025 | 970,000.00 |
| Dec 31, 2024 | 7.68 Mn |
| Dec 31, 2024 | 7.68 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | -294,000.00 |
| Jun 30, 2024 | -294,000.00 |
| Mar 31, 2024 | -823,000.00 |
| Mar 31, 2024 | -823,000.00 |
| Dec 31, 2023 | -8.18 Mn |
| Dec 31, 2023 | -8.18 Mn |
| Sep 30, 2023 | 8.06 Mn |
| Sep 30, 2023 | 8.06 Mn |